Breadcrumb

What's New at the RI-MUHC ?

New MUHC study calls for targeted screening of high-risk healthcare workers for tuberculosis

Tuberculosis (TB) is a recognized hazard for healthcare workers, but the annual screening strategy currently in place in Canada...

How a few drops of blood led to a breakthrough in immunology

Scientists from the Research Institute of the McGill University Health Centre (RI-MUHC) may have cracked the code to understanding...

Biofilms—the eradication has begun

Have you ever heard of biofilms? They are slimy, glue-like membranes that are produced by microbes, like bacteria and fungi, in order to...

The MUHC Foundation launches a $10-million fundraising campaign for research

More than 150 guests joined the McGill University Health Centre (MUHC) Foundation to celebrate the achievements of two Montreal...

Kidney graft success - does age and sex matter?

The success of kidney transplant is dependent on the age and sex of both the donor and the recipient, according to research published...

On the genetics trail

Researchers have identified the genetic mutation responsible for one patient's serious health problems, finally solving a medical...

Encouraging results for patients with aggressive brain cancer

Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types...

A prescription with legs!

A study from the Research Institute of the McGill University Health Centre (RI-MUHC) shows that physician-delivered step count...

What is high Lipoprotein(a), and should I be concerned?

A team of researchers from the Research Institute of the McGill University Health Center (RI-MUHC) found that elevations in a unusual...

New marker and potential therapy for triple negative breast cancer

Triple negative breast cancer (TNBC) is the most aggressive type of breast cancer, found in 15-20% of all cases. These breast tumors are...

Learn more about the RI-MUHC